13 September 2011 15:23 [Source: ICIS news]
HOUSTON (ICIS)--Gevo has been awarded two patents by the United States Patent and Trademark Office for technologies to produce bio-based isobutanol, the ?xml:namespace>
Gevo said the technologies help to turn an industrial yeast strain into a “highly efficient cell factory” to produce isobutanol (IBA).
One patent, for a “yeast organism producing isobutanol at a high yield”, focuses on converting an ethanol-producing yeast into an IBA-producing one.
“This significant discovery virtually eliminates ethanol production in yeast and enables Gevo’s yeast to survive and thrive by producing isobutanol at high yields,” the company said.
The second patent is for “methods of increasing dihydroxy acid dehydratase activity to improve production of fuels, chemicals, and amino acids”.
Brett Lund, Gevo executive vice president and general counsel, said the company used synthetic biology “to reprogramme the yeast” to make IBA instead of ethanol.
“In other words, we changed the yeast so that it makes what we want instead of what it wants, and we made it so it does it really well,”
Butamax officials were not immediately available for comment.
Last month Butamax said it had filed a lawsuit in the US against Gevo, alleging that Gevo had infringed one of Butamax’s newly issued patents on “foundational methods for low-cost production of biobutanol”.
US-headquartered DuPont and BP formed Butamax in 2009 to develop and commercialise biobutanol as a next-generation renewable biofuel for the transport market.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections